Anti-inflammatory and immunosuppressive glucocorticoids are used daily by millions of people around the world. These products are efficient, but they often lack convenience. AcuCort is therefore developing a small, fast dissolving and easy-to-use oral film containing a well-known glucocorticoid. Same effect, revolutionary administration.

New solution for treatment of viral eye infection.

Glactone Pharma develops novel drugs that target STAT3, a key transcription factor signaling pathway, for the treatment of advanced and drug resistant cancers to improve the lives of cancer patients. We strive to build strong science and robust data to deliver real and meaningful benefits to patients. Learn more about our projects. We develop unique small-molecule inhibitors of STAT3. Kullagatan 8, 252 20 Helsingborg, Sweden.

Innovative drug delivery platform for the benefit of patients and pharma industry. 2018-02-22 Year End Report 2017.

Current treatment of metastasized kidney cancer only, on average, prolongs the life for the suffering patients with a few months, and often the therapy has severe side-effects. Oncorena develops a drug based on the natural substance. Oncorena treatment for renal cancer. Oncorena develops a drug based on the natural substance orellanine, a highly kidney selective toxin from certain mushrooms.